Longzang Bio selects high-quality wild ginseng as the mother material and uses plant CMC cambium stem cell technology to directionally cultivate ginseng adventitious roots, enabling highly efficient enrichment of rare ginsenosides under intelligent stress conditions.

The content of key active components such as Rg3, Rh2, Rg5, and Rk1 is 320%–410% higher than that of traditional ginseng. The production cycle is shortened from decades to just 30–60 days, with zero pesticide residues, zero heavy metals, and zero environmental pollution throughout the process.

Products are accurately quantified by UPLC-MS/MS, complying with the national standard GB/T 41726-2022 and testing standards of the Chinese Academy of Sciences.

They can be widely used in innovative traditional Chinese medicine, adjuvant anti-tumor therapy, immune regulation, functional foods, and high-end skincare raw materials.

Core advantages include high purity, high activity, batch-to-batch consistency, and sustainable supply.

-

龙藏生物采用优质野山参母本，通过植物 CMC 形成层干细胞技术定向培育人参不定根，在智能胁迫环境下实现稀有人参皂苷高效富集。Rg3、Rh2、Rg5、Rk1 等关键活性成分含量较传统人参提升 320%–410%，生产周期从数十年缩短至 30–60 天，全程无农残、无重金属、无环境污染。产品采用 UPLC-MS/MS 精准定量，符合 GB/T 41726-2022 国标及中科院检测标准，可广泛应用于创新中药、抗肿瘤辅助、免疫调节、功能食品及高端护肤原料等领域，具备高纯度、高活性、批次稳定、可持续供应的核心优势。